Results 101 to 110 of about 25,648 (169)

Mel Greaves: Cancer through the Lens of Evolution [PDF]

, 2016
RAMACHANDRAN, P
core   +2 more sources

Population Pharmacokinetic Analyses and Exposure-Efficacy Relationships of Venetoclax in Chinese Pediatric Patients with Hematological Malignancy in a Real-World Setting. [PDF]

Drug Des Devel Ther
Zhao Y, Song X, Zhang L, Zhu Y, Chen J, Gong Y, Luo X, He H, Zhang X, Huang L.   +9 more
europepmc   +1 more source

High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. [PDF]

J Med Cases
Gutierrez CLD, Quero-Taggaoa AKH, Uy TCF, Veloso JAD.   +3 more
europepmc   +1 more source

Differential responses to the combination of navitoclax and venetoclax with doxorubicin in murine models of triple negative breast cancer. [PDF]

Front Cell Dev Biol
As Sobeai HM, Alanazi AM, Alotaibi F, Alhoshani A, Alhazzani K, Almutairi MM, Almudimeegh S, Al-Ramadi BK, Chakraborty E, Saleh T, Gewirtz DA, Harada H, Alotaibi MR.   +12 more
europepmc   +1 more source

Real‑life diagnostic and therapeutic approach to CLL/SLL in tuscany: the 2025 consensus. [PDF]

Clin Exp Med
D'Amato M, Rapolla CM, Benedetti E, Bocchia M, Capochiani E, Carlomagno G, Ciofini S, Giachetti R, Maestrini G, Moretti S, Nasso D, Papini G, Pirrotta MT, Simonetti F, Santini S, Vannucchi A, Galimberti S, Sanna A.   +17 more
europepmc   +1 more source

Studying clonal heterogeneity of acute myeloid leukemia under nutrient and chemotherapy stress. [PDF]

Blood Adv
Mayerhofer C, Crompton E, Mayerhofer E, Kristiansen T, Fukushima T, Keyes S, Sharda A, Li D, Da Silva C, Shrestha D, Kiem A, Feuchtinger T, Scadden DT, Miller PG.   +13 more
europepmc   +1 more source

DDX41-Mutated AML: A Case Report and Perspectives. [PDF]

JCO Precis Oncol
Yashar WM, Eide CA, Kurtz SE, Long N, Johnson KJ, Tognon CE, Druker BJ, Tyner JW, Swords R.   +8 more
europepmc   +1 more source

Ibrutinib regimens versus chemoimmunotherapy in older patients with untreated CLL [PDF]

, 2018
Bartlett, Nancy L.
core   +1 more source

Synergistic targeting of eIF4A-mediated translation initiation and apoptosis in acute myeloid leukemia. [PDF]

Blood Neoplasia
Lee YS, Good JD, Awais N, Eschle BK, Lineberry MS, Lin J, Wunderlich M, Thibodeau J, Edwards H, Teo JL, Bibeau S, Wollman M, Karadimov G, Sariipek N, Salik B, Acosta J, Noel J, Cucchi DGJ, DePasquale EAK, Gokhale PC, Ritz J, Ge Y, Miller PG, Najm FJ, Stone RM, Garcia JS, Lane AA, Jones CL, van Galen P.   +28 more
europepmc   +1 more source

Bcl-2 inhibitor resistance in diffuse large b-cell lymphoma: establishing a prognostic signature and targeting alpha protein kinase 1. [PDF]

Front Oncol
Ma J, Wang Y, Liu H, Deng Y, Shi Y, Wei L, Chen Q, Wang C, Yu L.   +8 more
europepmc   +1 more source